Sector Highlights at the 2019 Annual Meeting

The LES Life Sciences Sector sessions during the 2019 LES Annual Meeting cover the latest trends in areas such as pharmaceutical, biotech, biomedical devices and diagnostics & genomics.

Check Out These Life Sciences Sessions:

Licensing in Life Sciences and Information and Communication Technology: More Commonalities Than You Ever Expected

This panel will use CRISPR technology as an example of how the both science and technology industries can learn from one another, comparing licensing strategies and practices, and identifying areas of potential cross-pollination.

PD1-PDL1 Immune Checkpoint Inhibitors, from Academic Discovery to Dominant Clinical Target

Strategic issues in patenting and licensing basic discoveries will be explored using the clinical development of PD-1 as a specific case study and discussion point.

Challenges with Repurposed Drugs

This session will address the challenges that are faced by TTOs and companies when dealing with repurposed drugs and how these can be overcome.

Modern Medicine—Is There Anything Left to Patent?

The panel will review the evolution and current state of the law and suggest strategies to obtain meaningful patent protection for inventions in these rapidly evolving areas of medical technology in the U.S. and abroad.

Take a look at the Life Sciences schedule visit https://lesmeetings.org/agenda/ and Select Life Sciences Sector.

The LES High-Tech Sector sessions during the 2019 LES Annual Meeting cover the latest technological trends in many areas from semiconductors, software and automotive to emerging applications in AI and IoT.

Check Out These High-Tech Sessions:

The Judicious Gumshoe: Performing Due Diligence

From the varied perspectives of large pharma in-licensing, small biotech outlicensing, and transactions in high tech, this practical session will reveal experiences and lessons learned on due diligence in IP transactions.

Qualcomm Battles: SEP/FRAND Litigation Landscape

The panel will discuss recent developments in the SEP/FRAND arena with a focus on the Qualcomm rulings.

Will Federal Definitions of Emerging Technology Stall Your Next International Licensing Opportunity? How Changing U.S. Export Control Laws May Impact International Licensing

The panel of corporate licensing professionals, senior legal counsel for foreign trade matters, and regulators will discuss the laws, recent changes and the likely impact on product sales, tech transfer and licensing.

State of the Sectors: Hot Trends in Technology and IP across Industry Sectors

In this session the audience will be invited to actively participate in the creation of a “State of the Sectors Report” that will later be shared with the larger LES and LESI membership.

Take a look at the High-Tech schedule visit https://lesmeetings.org/agenda/ and Select High-Tech Sector.

IUGI—Industry-University-Government Interface: T he LES IUGI Sector sessions during the 2019 Annual Meeting discuss the interaction, collaboration, and best-practice sharing between licensing and technology transfer professionals and the greater financial community.

Check Out These IUGI Sessions:

Rebalancing the IP Economy: Developments in Bulk Patent Cross-Licensing and Markets

The panel will explore previously tried bulk licensing models and pros and cons of current and new licensing models.

Exit Strategies: Valuation and Taxation Considerations in M&A Deals

This cross-sector panel of corporate buyers, taxation and valuation experts, will explore issues related to taxation and valuation and how they impact the structure, pricing and reporting of M&A deals.

Top 10 Court Decisions of 2019 Affecting Licensing

This workshop will identify and discuss the Top 10 court decisions affecting licensing over the past year. Learn how these cases impact the way we draft, and negotiate patent and technology license agreements.

The Not So (Trade) Secret Issues Faced by Huawei, Quicken, and Uber

This panel will address recent trade secret cases, and significant issues and accusations of fraud, along with the U.S. government’s current stance on trade secrets.

Take a look at the IUGI schedule visit https://lesmeetings.org/agenda/ and Select IUGI Sector.